| Title |
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
|
|---|---|
| Published in |
BMC Psychiatry, September 2013
|
| DOI | 10.1186/1471-244x-13-237 |
| Pubmed ID | |
| Authors |
David Coghill, Tobias Banaschewski, Alessandro Zuddas, Antonio Pelaz, Antonella Gagliano, Manfred Doepfner |
| Abstract |
The stimulant methylphenidate (MPH) has been a mainstay of treatment for attention-deficit/hyperactivity disorder (ADHD) for many years. Owing to the short half-life and the issues associated with multiple daily dosing of immediate-release MPH formulations, a new generation of long-acting MPH formulations has emerged. Direct head-to-head studies of these long-acting MPH formulations are important to facilitate an evaluation of their comparative pharmacokinetics and efficacy; however, to date, relatively few head-to-head studies have been performed.The objective of this systematic review was to compare the evidence available from head-to-head studies of long-acting MPH formulations and provide information that can guide treatment selection. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 260 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Portugal | 1 | <1% |
| Colombia | 1 | <1% |
| Germany | 1 | <1% |
| Chile | 1 | <1% |
| Brazil | 1 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 254 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 41 | 16% |
| Student > Bachelor | 32 | 12% |
| Researcher | 28 | 11% |
| Student > Ph. D. Student | 23 | 9% |
| Other | 20 | 8% |
| Other | 56 | 22% |
| Unknown | 60 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 59 | 23% |
| Psychology | 45 | 17% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 6% |
| Social Sciences | 13 | 5% |
| Nursing and Health Professions | 10 | 4% |
| Other | 49 | 19% |
| Unknown | 68 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 September 2023.
All research outputs
#4,889,505
of 25,882,826 outputs
Outputs from BMC Psychiatry
#2,007
of 5,541 outputs
Outputs of similar age
#40,926
of 217,867 outputs
Outputs of similar age from BMC Psychiatry
#36
of 81 outputs
Altmetric has tracked 25,882,826 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,541 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.4. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 217,867 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 81 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.